Literature DB >> 1674967

Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus.

L L Perry1, D L Lodmell.   

Abstract

Mice of the SJL/J and BALB/cByJ inbred strains are naturally resistant to street rabies virus (SRV) injected via the intraperitoneal route. To determine the cellular mechanism of resistance, monoclonal antibodies specific for CD4+ or CD8+ subsets of T cells were used to deplete the respective cell population in SRV-infected animals. Elimination of CD4+ T-helper cells abrogated the production of immunoglobulin G (IgG) neutralizing antibodies in response to rabies virus infection and reversed the resistant status of SJL/J and BALB/cByJ mice. In contrast, in vivo depletion of CD8+ cytotoxic T cells had no measurable effect on host resistance to SRV. These results indicate that serum neutralizing antibodies of the IgG class are a primary immunological mechanism of defense against rabies virus infection in this murine model of disease. CD8+ cytotoxic T lymphocytes, which have been shown to transfer protection in other rabies virus systems, appear to have no role in protecting mice against intraperitoneally injected SRV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674967      PMCID: PMC241322     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Histoincompatibility associated with the X chromosome in mice.

Authors:  D W BAILEY
Journal:  Transplantation       Date:  1963-01       Impact factor: 4.939

2.  Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein.

Authors:  H C Ertl; B Dietzschold; M Gore; L Otvos; J K Larson; W H Wunner; H Koprowski
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody.

Authors:  M Rodriguez; S Sriram
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

4.  Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.

Authors:  A A Nash; A Jayasuriya; J Phelan; S P Cobbold; H Waldmann; T Prospero
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

5.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

6.  Interferon induced within the central nervous system during infection is inconsequential as a mechanism responsible for murine resistance to street rabies virus.

Authors:  D L Lodmell; D L Wiedbrauk; L C Ewalt
Journal:  J Gen Virol       Date:  1989-02       Impact factor: 3.891

7.  Interleukin 2 increases protection against experimental rabies.

Authors:  P Perrin; M L Joffret; C Leclerc; D Oth; P Sureau; L Thibodeau
Journal:  Immunobiology       Date:  1988-05       Impact factor: 3.144

8.  Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies.

Authors:  J Esposito; K Brechling; G Baer; B Moss
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

9.  The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.

Authors:  M E Andrew; B E Coupar; D B Boyle; G L Ada
Journal:  Scand J Immunol       Date:  1987-01       Impact factor: 3.487

10.  Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients.

Authors:  E Celis; D Ou; B Dietzschold; H Koprowski
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

View more
  29 in total

Review 1.  Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Authors:  P P Sanna; D R Burton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 2.  Experimental rabies vaccines for humans.

Authors:  James P McGettigan
Journal:  Expert Rev Vaccines       Date:  2010-10       Impact factor: 5.217

3.  Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice.

Authors:  Mutsuyo Takayama-Ito; Naoto Ito; Kentaro Yamada; Nobuyuki Minamoto; Makoto Sugiyama
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

4.  Polygenic control of antibody production and correlation with vaccine induced resistance to rabies virus in high and low antibody responder mice.

Authors:  M De Franco; S Massa; R C Vassão; M Siqueira; O A Sant'Anna
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 5.  Superantigen related to rabies.

Authors:  M Lafon; A Galelli
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice.

Authors:  B P Madhu; K P Singh; M Saminathan; R Singh; N Shivasharanappa; A K Sharma; Yashpal S Malik; K Dhama; V Manjunatha
Journal:  Virusdisease       Date:  2016-09-01

7.  Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15.

Authors:  H J Super; K J Hasenkrug; S Simmons; D M Brooks; R Konzek; K D Sarge; R I Morimoto; N A Jenkins; D J Gilbert; N G Copeland; W Frankel; B Chesebro
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

8.  Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.

Authors:  B S Huneycutt; Z Bi; C J Aoki; C S Reiss
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  In vivo role of lymphocyte subpopulations in the control of virus excretion and mucosal antibody responses of cattle infected with rotavirus.

Authors:  G Oldham; J C Bridger; C J Howard; K R Parsons
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice.

Authors:  M N Robertson; G J Spangrude; K Hasenkrug; L Perry; J Nishio; K Wehrly; B Chesebro
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.